Cervical Cancer Prevention and Treatment: An Overview

Author:

Jose Sonja1,Balakrishnan B. R.2

Affiliation:

1. Research Scholar, Department of Pharmaceutical Analysis, Vinayaka Mission College of Pharmacy, Vinayaka Mission’s Research Foundation (Deemed to be University), Salem, Tamilnadu.

2. Professor and Head, Department of Pharmacognosy, Vinayaka Mission College of Pharmacy, Vinayaka Mission’s Research Foundation (Deemed to be University), Salem, Tamilnadu.

Abstract

Cervical cancer imposes a huge global burden. Cervical carcinoma is one of the most common and feared diseases of women, and in India, it accounts for 16 per cent of total cervical cancer cases occurring globally. The situation is more alarming in the rural areas where the majority of women are illiterate and ignorant about the hazards of cervical cancer. To date, various studies have been conducted on the risk factors associated with cervical cancer. Accumulated evidence has demonstrated the reasons by which HPV infection causes carcinogenesis. Two viral oncoproteins E6 and E7could play a key role in the HPV-infected cervical cancers. It has been documented that not all integrations necessarily depend on the E6 and E7 oncogenes expression. Currently, clinical treatment managements for cervical cancer typically include surgery, radiotherapy, and platinum-based chemotherapy. Treatment for early stage disease often is surgical therapy such as cervical conisation, total simple hysterectomy, or radical hysterectomy based on extent of spread of cervical cancer. In the recent years, a series of systemic treatments, for instance, the platinum-based chemotherapy and the recent FDA approved pembrolizumab, have applied for recurrent and advanced cervical cancer. Although screening and advanced therapeutic strategies have improved the survival rate of cervical cancer, some patients still die due to metastasis and drug resistance. Without a doubt, HPV vaccination could pre-vent the development of cervical cancer; however, many patients’ in underdeveloped countries cannot get HPV vaccination due to economic condition. The aim of this study was to investigate the incidence, mortality, and geographical distribution of cervical cancer and its risk factors in the world and study the molecular mechanisms of cervical cancer development and progression, to discover the novel molecular diagnostic methods and systemic management for cervical cancer. The findings of this study demonstrated that several factors including sexually transmitted infections, reproductive factors, hormonal influences, genetics and host factors are responsible for the incidence of cervical cancer. The results of this review study suggested that combination of biological, economic and health factors contributes to the incidence of cervical cancer. A large proportion cervical cancer can be prevented by prevention programs, lifestyle enhancement, smoking cessation, and timely and effective treatment of pre-cancerous lesions.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3